Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: A systematic review

I Rodriguez-Cobo; Yen-Fu Chen; Babatunde Olowokure; Ian Litchfield

doi:10.1016/j.vaccine.2008.09.042

Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: A systematic review

I Rodriguez-Cobo, Yen-Fu Chen, Babatunde Olowokure, Ian Litchfield

Applied Health Research

Research output: Contribution to journal › Review article

15 Citations (Scopus)

Abstract

Pertussis continues to be an important cause of morbidity and mortality in children too young to be fully protected despite high vaccination coverage. This has been attributed to waning immunity in older people, leading to the development of strategies to increase levels of immunity. A systematic review was conducted to assess the clinical and cost effectiveness of four population-based strategies for pertussis booster vaccination: single booster at 12-24 months old, single pre-school booster, single adolescent booster and Multiple boosters in adulthood every 10 years. Electronic databases and Internet resources were searched to June 2006. Nine observational studies, four mathematical models and eight economic evaluations were included, evaluating four different strategies. Strong evidence to recommend any of these strategies was not found. (C) 2008 Elsevier Ltd. All rights reserved.

Original language	English
Pages (from-to)	6768-6776
Number of pages	9
Journal	Vaccine
Volume	26
Issue number	52
DOIs	https://doi.org/10.1016/j.vaccine.2008.09.042
Publication status	Published - 1 Dec 2008

Keywords

Pertussis vaccination
Systematic review
Economic evaluation
Booster strategy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2008.09.042

Fingerprint

Dive into the research topics of 'Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: A systematic review'. Together they form a unique fingerprint.

Cite this

@article{db8a69e8243e400a8fe07fd9b6d8f350,

title = "Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: A systematic review",

abstract = "Pertussis continues to be an important cause of morbidity and mortality in children too young to be fully protected despite high vaccination coverage. This has been attributed to waning immunity in older people, leading to the development of strategies to increase levels of immunity. A systematic review was conducted to assess the clinical and cost effectiveness of four population-based strategies for pertussis booster vaccination: single booster at 12-24 months old, single pre-school booster, single adolescent booster and Multiple boosters in adulthood every 10 years. Electronic databases and Internet resources were searched to June 2006. Nine observational studies, four mathematical models and eight economic evaluations were included, evaluating four different strategies. Strong evidence to recommend any of these strategies was not found. (C) 2008 Elsevier Ltd. All rights reserved.",

keywords = "Pertussis vaccination, Systematic review, Economic evaluation, Booster strategy",

author = "I Rodriguez-Cobo and Yen-Fu Chen and Babatunde Olowokure and Ian Litchfield",

year = "2008",

month = dec,

day = "1",

doi = "10.1016/j.vaccine.2008.09.042",

language = "English",

volume = "26",

pages = "6768--6776",

journal = "Vaccine",

publisher = "Elsevier",

number = "52",

}

Rodriguez-Cobo, I, Chen, Y-F, Olowokure, B & Litchfield, I 2008, 'Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: A systematic review', Vaccine, vol. 26, no. 52, pp. 6768-6776. https://doi.org/10.1016/j.vaccine.2008.09.042

Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: A systematic review. / Rodriguez-Cobo, I; Chen, Yen-Fu; Olowokure, Babatunde et al.
In: Vaccine, Vol. 26, No. 52, 01.12.2008, p. 6768-6776.

Research output: Contribution to journal › Review article

TY - JOUR

T1 - Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: A systematic review

AU - Rodriguez-Cobo, I

AU - Chen, Yen-Fu

AU - Olowokure, Babatunde

AU - Litchfield, Ian

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Pertussis continues to be an important cause of morbidity and mortality in children too young to be fully protected despite high vaccination coverage. This has been attributed to waning immunity in older people, leading to the development of strategies to increase levels of immunity. A systematic review was conducted to assess the clinical and cost effectiveness of four population-based strategies for pertussis booster vaccination: single booster at 12-24 months old, single pre-school booster, single adolescent booster and Multiple boosters in adulthood every 10 years. Electronic databases and Internet resources were searched to June 2006. Nine observational studies, four mathematical models and eight economic evaluations were included, evaluating four different strategies. Strong evidence to recommend any of these strategies was not found. (C) 2008 Elsevier Ltd. All rights reserved.

AB - Pertussis continues to be an important cause of morbidity and mortality in children too young to be fully protected despite high vaccination coverage. This has been attributed to waning immunity in older people, leading to the development of strategies to increase levels of immunity. A systematic review was conducted to assess the clinical and cost effectiveness of four population-based strategies for pertussis booster vaccination: single booster at 12-24 months old, single pre-school booster, single adolescent booster and Multiple boosters in adulthood every 10 years. Electronic databases and Internet resources were searched to June 2006. Nine observational studies, four mathematical models and eight economic evaluations were included, evaluating four different strategies. Strong evidence to recommend any of these strategies was not found. (C) 2008 Elsevier Ltd. All rights reserved.

KW - Pertussis vaccination

KW - Systematic review

KW - Economic evaluation

KW - Booster strategy

U2 - 10.1016/j.vaccine.2008.09.042

DO - 10.1016/j.vaccine.2008.09.042

M3 - Review article

C2 - 18835414

VL - 26

SP - 6768

EP - 6776

JO - Vaccine

JF - Vaccine

IS - 52

ER -